Vivos Therapeutics, Inc. (VVOS) Misses Q3 EPS by 1c

Vivos Therapeutics, Inc. (NASDAQ: VVOS) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $3.72 million.

For earnings history and earnings-related data on Vivos Therapeutics, Inc. (VVOS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI